行情

VNRX

VNRX

VOLITIONRX
AMEX

实时行情|Nasdaq Last Sale

3.080
0.000
0.00%
盘后: 3.320 +0.24 +7.79% 18:09 09/21 EDT
开盘
3.130
昨收
3.080
最高
3.200
最低
3.060
成交量
14.59万
成交额
--
52周最高
6.67
52周最低
2.850
市值
1.64亿
市盈率(TTM)
-7.2968
分时
5日
1月
3月
1年
5年
生命科学公司投资者演示文稿现在可供点播观看
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the...
GlobeNewswire · 1天前
生命科学虚拟投资者会议：公司高管于 9 月 16 日现场直播
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private...
GlobeNewswire · 09/10 12:35
VNRX：Nu.Q Vet Cancer Screening Test 的收入从 beta 测试开始稳定； Silver One 预计将在 2021 年底产生收入。
By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT
Benzinga · 08/18 19:40
Sidoti Microcap 虚拟会议
ACCESSWIRE · 08/18 12:45
将于 2021 年 8 月 17 日至 19 日在 SNN 网络夏季虚拟活动上发表主题演讲、教育小组和 60 家公司
The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience.
ACCESSWIRE · 08/16 12:32
Diamond Equity Research 新兴增长邀请赛 2021 年夏季聚焦虚拟会议
30 Minute presenting time slots from 9am to 12pm EST August 17th, 2021Presentation times and links distributed for all presenting companiesInvestors will be provided time after presentation to ask questions to management teamsWe welcome all institutional a...
GlobeNewswire · 08/12 13:00
Brief-VolitionRX Ltd 第二季度净亏损 560 万美元
reuters.com · 08/11 21:29
VolitionRx Limited 公布 2021 年第二季度财务业绩和业务更新
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June 30, 2021. Volition management will host a conference call tomorrow, August 12 at 8:00 a.m. U.S. Eastern Time to ...
PR Newswire · 08/11 20:10
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解VNRX最新的财务预测，通过VNRX每股收益，每股净资产，每股现金流等数据分析VOLITIONRX近期的经营情况，然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测VNRX价格均价为8.00，最高价位10.00，最低价为6.00。
EPS
机构持股
总机构数: 24
机构持股: 302.25万
持股比例: 5.69%
总股本: 5,314.52万
类型机构数股数
增持
9
10.15万
建仓
1
802
减持
4
8.42万
平仓
2
3.56万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.10%
医疗设备和用品
+0.22%
高管信息
Chairman/Executive Director
Martin Faulkes
Chief Executive Officer/President/Director
Cameron Reynolds
Chief Financial Officer/Treasurer
Terig Hughes
Corporate Executive
Salvatore Butera
Corporate Executive
Jasmine Kway
Chief Scientific Officer
Jacob Micallef
Other
Gael Forterre
Other
Jason Terrell
Secretary
Rodney Rootsaert
Independent Director
Phillip Barnes
Independent Director
Richard Brudnick
Independent Director
Alan Colman
Independent Director
Edward Futcher
Independent Director
Guy Innes
Independent Director
Kim Nguyen
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
VNRX 简况
VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

微牛提供VolitionRX Ltd(AMEX-VNRX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的VNRX股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易VNRX股票基本功能。